In what could represent a major advance in the fight against coronavirus, a Rutgers University research lab says it has developed a new test using existing automated technology able to analyze tens of thousands of patient samples each day to detect COVID-19. At the same time, RUCDR Infinite Biologics — a unit of Rutgers’ Human Genetics Institute of New Jersey — submitted an emergency use authorization request for a saliva collection method that would allow for far broader screening than what is now even possible. To read the full article.
Home / News / New coronavirus test developed at Rutgers can screen thousands and it’s as simple as a spit in a tube
Recent Posts
- Extreme Monsoon Changes Threaten the Bay of Bengal’s Role as a Critical Food Source.
- New NJACTS Publication
- Join NJ ACTS Biostatistics, Epidemiology, Research Design (BERD) Workshop Series on June 19th
- NJIT Study Probes Genetic ‘Smoking Gun,’ Health Risks of Vaping Among Gen Z.
- Measles cases seem to be slowing down in the US. What’s behind it?
Categories
- Community (2,270)
- Covid (986)
- CTO Events (6)
- News (2,892)
- Pilots (21)